Kura Oncology, Inc.KURANASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR+94.7%
5Y CAGR-31.5%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
+94.7%/yr
Quarterly compound
5Y CAGR
-31.5%/yr
Recent acceleration
Percentile
P77
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.70% |
| Q3 2025 | -4.84% |
| Q2 2025 | -8.25% |
| Q1 2025 | -2.16% |
| Q4 2024 | 58.75% |
| Q3 2024 | -7.04% |
| Q2 2024 | -7.00% |
| Q1 2024 | 23.38% |
| Q4 2023 | -5.24% |
| Q3 2023 | -4.24% |
| Q2 2023 | 16.14% |
| Q1 2023 | -6.65% |
| Q4 2022 | 1.86% |
| Q3 2022 | -4.97% |
| Q2 2022 | -5.45% |
| Q1 2022 | -6.64% |
| Q4 2021 | -4.83% |
| Q3 2021 | -4.06% |
| Q2 2021 | -5.70% |
| Q1 2021 | -4.16% |
| Q4 2020 | 90.60% |
| Q3 2020 | -3.81% |
| Q2 2020 | 55.88% |
| Q1 2020 | -6.41% |
| Q4 2019 | -4.96% |
| Q3 2019 | -4.17% |
| Q2 2019 | 56.64% |
| Q1 2019 | -7.00% |
| Q4 2018 | -4.76% |
| Q3 2018 | 47.73% |
| Q2 2018 | -8.36% |
| Q1 2018 | 47.58% |
| Q4 2017 | -7.04% |
| Q3 2017 | 84.64% |
| Q2 2017 | -9.81% |
| Q1 2017 | -11.32% |
| Q4 2016 | -8.50% |
| Q3 2016 | -6.65% |
| Q2 2016 | 1.69% |
| Q1 2016 | -7.88% |